Host Dr. Amanda Redfern welcomes Dr. Claudia Prospero Ponce, a neuro-ophthalmologist and ocular pathologist, to share her unique perspective on how to diagnose giant cell arteritis (GCA) when temporal artery biopsies are not classically positive.

For more information about pathological markers in GCA, check out this paper referenced in the episode: Sultan H, Smith SV, Lee AG, Chévez-Barrios P. Pathologic Markers Determining Prognosis in Patients With Treated or Healing Giant Cell Arteritis. Am J Ophthalmol. 2018;193:45-53.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

Dr. Nisha Mehta, founder of Physician Side Gigs, and Dr. Jim Dahle, founder of The White Coat Investor, join host Dr. Jay Sridhar to discuss the One Big Beautiful Bill Act and its implications for physicians and ophthalmologists in particular.

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.

In July, the Centers for Medicare and Medicaid (CMS) proposed catastrophic changes to Medicare reimbursement systems that, if finalized, will significantly affect ophthalmology and all specialty care. The impact on cataract surgery reimbursements alone would amount to an 11% reduction in payment.

In today’s episode, host Dr. Andrew Pouw welcomes three guests to discuss these highly complex and concerning cuts: Dr. John McAllister, the Academy’s Secretary for Federal Affairs; Brandy Keys, the Academy’s Director of Health Policy; and Rebecca Hyder, the Academy’s Vice President of Government Affairs. Listen, share, and advocate to help us prevent these changes.

Related Academy Resources:

• Summary of CMS Medicare Physician Fee Schedule
• Impact of the Efficiency Adjustment
• Impact to Indirect Practice Expense (PE)

For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.